Sugarloaf Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $172K | Sell |
331
-29
| -8% | -$15.1K | 0.03% | 183 |
|
|
2024
Q3 | $223K | Buy |
360
+44
| +14% | +$27.2K | 0.04% | 151 |
|
|
2024
Q2 | $175K | Buy |
316
+2
| +0.6% | +$1.11K | 0.04% | 161 |
|
|
2024
Q1 | $183K | Buy |
314
+20
| +7% | +$11.6K | 0.04% | 160 |
|
|
2023
Q4 | $156K | Buy |
294
+19
| +7% | +$10.1K | 0.04% | 177 |
|
|
2023
Q3 | $139K | Buy |
275
+48
| +21% | +$24.3K | 0.04% | 181 |
|
|
2023
Q2 | $118K | Buy |
227
+29
| +15% | +$15.1K | 0.03% | 190 |
|
|
2023
Q1 | $114K | Buy |
198
+12
| +6% | +$6.92K | 0.03% | 188 |
|
|
2022
Q4 | $102K | Buy |
186
+12
| +7% | +$6.61K | 0.03% | 188 |
|
|
2022
Q3 | $88K | Buy |
174
+36
| +26% | +$18.2K | 0.02% | 211 |
|
|
2022
Q2 | $74K | Buy |
138
+4
| +3% | +$2.15K | 0.02% | 224 |
|
|
2022
Q1 | $79K | Buy |
134
+18
| +16% | +$10.6K | 0.02% | 222 |
|
|
2021
Q4 | $77K | Buy |
116
+63
| +119% | +$41.8K | 0.02% | 230 |
|
|
2021
Q3 | $30K | Hold |
53
| – | – | 0.01% | 350 |
|
|
2021
Q2 | $27K | Hold |
53
| – | – | 0.01% | 371 |
|
|
2021
Q1 | $24 | Hold |
53
| – | – | 0.01% | 378 |
|
|
2020
Q4 | $25K | Hold |
53
| – | – | 0.01% | 347 |
|
|
2020
Q3 | $23K | Hold |
53
| – | – | 0.01% | 336 |
|
|
2020
Q2 | $19K | Hold |
53
| – | – | 0.01% | 361 |
|
|
2020
Q1 | $15K | Hold |
53
| – | – | 0.01% | 380 |
|
|
2019
Q4 | $17K | Buy |
+53
| New | +$17K | 0.01% | 395 |
|